Literature DB >> 22076912

Do levodopa treatments modify the morphology of the parkinsonian brain?

Anthony C Vernon, Michel Modo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22076912     DOI： 10.1002/mds.24018

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  7 in total

1.  Progression of brain atrophy in the early stages of Parkinson's disease: a longitudinal tensor-based morphometry study in de novo patients without cognitive impairment.

Authors:  Carlo Tessa; Claudio Lucetti; Marco Giannelli; Stefano Diciotti; Michele Poletti; Sabrina Danti; Filippo Baldacci; Claudio Vignali; Ubaldo Bonuccelli; Mario Mascalchi; Nicola Toschi
Journal:  Hum Brain Mapp       Date:  2014-01-22       Impact factor: 5.038

Review 2.  Maladaptive plasticity in levodopa-induced dyskinesias and tardive dyskinesias: old and new insights on the effects of dopamine receptor pharmacology.

Authors:  Antonio Cerasa; Alfonso Fasano; Francesca Morgante; Giacomo Koch; Aldo Quattrone
Journal:  Front Neurol       Date:  2014-04-09       Impact factor: 4.003

3.  Magnetic resonance imaging and tensor-based morphometry in the MPTP non-human primate model of Parkinson's disease.

Authors:  Michel Modo; William R Crum; Madeline Gerwig; Anthony C Vernon; Priya Patel; Michael J Jackson; Sarah Rose; Peter Jenner; Mahmoud M Iravani
Journal:  PLoS One       Date:  2017-07-24       Impact factor: 3.240

4.  Morphometric changes in the reward system of Parkinson's disease patients with impulse control disorders.

Authors:  Clelia Pellicano; Flavia Niccolini; Kit Wu; Sean S O'Sullivan; Andrew D Lawrence; Andrew J Lees; Paola Piccini; Marios Politis
Journal:  J Neurol       Date:  2015-09-26       Impact factor: 4.849

Review 5.  Brain morphometry and the neurobiology of levodopa-induced dyskinesias: current knowledge and future potential for translational pre-clinical neuroimaging studies.

Authors:  Clare J Finlay; Susan Duty; Anthony C Vernon
Journal:  Front Neurol       Date:  2014-06-12       Impact factor: 4.003

Review 6.  The Effectiveness of Transcranial Brain Stimulation in Improving Clinical Signs of Hyperkinetic Movement Disorders.

Authors:  Ignacio Obeso; Antonio Cerasa; Aldo Quattrone
Journal:  Front Neurosci       Date:  2016-01-07       Impact factor: 4.677

7.  Neuroanatomical and Microglial Alterations in the Striatum of Levodopa-Treated, Dyskinetic Hemi-Parkinsonian Rats.

Authors:  Edward J R Fletcher; Clare J Finlay; Ana Amor Lopez; William R Crum; Anthony C Vernon; Susan Duty
Journal:  Front Neurosci       Date:  2020-09-15       Impact factor: 4.677
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.